Moffitt at ASCO 2026

Live from #ASCO26, I spoke with Dr. Vernon Sondak (@VernSondakMD) of @Moffittnews, about his work advancing melanoma research and treatment.

As chair of Moffitt’s Department of Cutaneous Oncology, Dr. Sondak has helped build one of the world’s leading multidisciplinary programs… pic.twitter.com/rMSXN7kEg6

— Dr. Patrick Hwu (@PatrickHwuMD) May 30, 2026

From #ASCO26, Nikhil Khushalani, MD (@DrKhushalani), and Vernon Sondak, MD (@VernSondakMD), discuss emerging melanoma research that could help refine treatment strategies and improve quality of life for patients.

Highlights include new data on treatment de-escalation for… pic.twitter.com/pHp9RpZfnQ

— Moffitt Cancer Center (@MoffittNews) June 2, 2026

Live from #ASCO26, I spoke with Dr. Kumar Karyampudi about @MoffittNews' work in cell therapies.

Through Moffitt’s unique research and clinical ecosystem, teams are helping move cell therapy approaches from the lab to the clinic and expand access to novel treatments for… pic.twitter.com/Ikh7tEWxHF

— Dr. Patrick Hwu (@PatrickHwuMD) May 30, 2026

During #ASCO26, I spoke with Dr. Peter Forsyth (@PeterForsyth27), chair of @MoffittNews' Neuro-Oncology Program, about research aimed at improving treatment for brain tumors and melanoma that spreads to the brain. #ASCO26 #MoffittASCO26 pic.twitter.com/gkRoOVulMm

— Dr. Patrick Hwu (@PatrickHwuMD) June 1, 2026

While at #ASCO26, I spoke with Dr. Andrew Kuykendall (@KuykendallMd), assistant member in Malignant Hematology at @Moffittnews, about his work advancing research and treatment for rare blood cancers.

His research focuses on finding new treatment options for patients with… pic.twitter.com/jvxitcEh4E

— Dr. Patrick Hwu (@PatrickHwuMD) May 30, 2026

During #ASCO26, I spoke with Dr. Hatem Soliman, breast oncologist @MoffittNews, about personalized cancer vaccines and breast cancer immunotherapy. #ASCO26 #MoffittASCO26 pic.twitter.com/1rxVnNwk1n

— Dr. Patrick Hwu (@PatrickHwuMD) May 31, 2026

During #ASCO26, Martine Extermann, MD, PhD, shares research examining genetic associations with chemotherapy-induced nausea and vomiting and insights that may help advance supportive cancer care. #MoffittASCO26 pic.twitter.com/t3vzKKn19S

— Moffitt Cancer Center (@MoffittNews) May 30, 2026

New technologies continue to shape cancer research. From his poster at #ASCO26, David Kaldas, MD (@DavidKaldas_MD), shares research exploring an AI-enabled approach to improving recognition of disease progression following BCMA CAR-T therapy. #MoffittASCO26 pic.twitter.com/mTmB3PtDj2

— Moffitt Cancer Center (@MoffittNews) June 1, 2026

From wearable-monitored activity to virtual exercise support, Mohammed Al-Jumayli, MD (@Mjumayli2016), shares research at #ASCO26 exploring approaches to help older adults prepare for hepatobiliary cancer surgery. pic.twitter.com/VGFlT6mpmK

— Moffitt Cancer Center (@MoffittNews) May 30, 2026

While at #ASCO26, Ariosto Silva, MD, shares research exploring an AI framework designed to bring together clinical, laboratory and molecular data to support personalized cancer care and accelerate future treatment discoveries. #MoffittASCO26 pic.twitter.com/gBPtfubnl0

— Moffitt Cancer Center (@MoffittNews) June 1, 2026

While at #ASCO26, Hyo Han, MD, shares research exploring intratumoral dendritic cell therapy in HER2-positive breast cancer, from biomarker analysis to immunotherapy strategies. #MoffittASCO26 pic.twitter.com/CbvQDa9mOm

— Moffitt Cancer Center (@MoffittNews) May 30, 2026

During #ASCO26, Hatem Soliman, MD, shares research exploring a personalized dendritic cell vaccine approach for high-risk triple-negative breast cancer, highlighting precision medicine strategies designed to help prevent recurrence. #MoffittASCO26 pic.twitter.com/NSudeP4uW9

— Moffitt Cancer Center (@MoffittNews) June 1, 2026

While at #ASCO26, Peter Forsyth, MD (@PeterForsyth27), stopped by the booth to share research exploring patient-derived tumor models to identify potential treatment strategies for melanoma leptomeningeal disease. #MoffittASCO26 pic.twitter.com/jS9rb2iUCY

— Moffitt Cancer Center (@MoffittNews) May 30, 2026

‼️New findings from the SARC041 trial presented at #ASCO26 suggest abemaciclib significantly improved progression-free survival in patients with advanced dedifferentiated liposarcoma, supporting its potential as a new treatment option for this rare sarcoma subtype.

Moffitt’s… pic.twitter.com/nG0m8fdJJg

— Moffitt Cancer Center (@MoffittNews) June 1, 2026

🚨New results presented at #ASCO26 from the NHS-Galleri trial suggest multicancer early detection blood testing increased screen-detected cancers while reducing stage IV diagnoses and emergency cancer presentations.

Moffitt’s Marilyn Bui, MD (@DrBuiPathology), discusses the… pic.twitter.com/mh4ikRhBZu

— Moffitt Cancer Center (@MoffittNews) May 30, 2026

While at #ASCO26, Richard Kim, MD, stopped by the #MoffittASCO26 booth to discuss research exploring FGFR2-targeted treatment strategies, from real-world analyses in advanced cholangiocarcinoma to investigational approaches for patients with FGFR2-altered solid tumors, helping… pic.twitter.com/O5OuAMvpV9

— Moffitt Cancer Center (@MoffittNews) June 1, 2026

🚨New data from #ASCO26 and the RUBY trial suggest more than half of patients with dMMR/MSI-H advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy may achieve durable disease control with curative potential.

Moffitt’s Merry Jennifer Markham, MD… pic.twitter.com/MAo7KIT60w

— Moffitt Cancer Center (@MoffittNews) May 30, 2026